
Despite biotech slump, veterans of SVB and KKR launch investment firm
Enavate, started by alumni of SVB and KKR, will encourage treatment of specific diseases.
Read The StoryExploring the intersection of finance, pharma, and biotech
Enavate, started by alumni of SVB and KKR, will encourage treatment of specific diseases.
Read The Story